Naltrexone implant - Indevus
Alternative Names: VP 004Latest Information Update: 28 Oct 2021
At a glance
- Originator Valera Pharmaceuticals
- Class Anti-inflammatories; Antineoplastics; Antivirals; Cyclopropanes; Drug withdrawal therapies; Ethers; Eye disorder therapies; Irritable bowel syndrome therapies; Ketones; Morphinans; Non-opioid analgesics; Small molecules
- Mechanism of Action Opioid receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Opioid-related disorders
Most Recent Events
- 31 Mar 2009 Discontinued - Phase-I for Opioid abuse in USA (SC)
- 23 Mar 2009 Indevus Pharmaceuticals has been acquired by Endo Pharmaceuticals
- 08 Nov 2006 Phase-I clinical trials in Opioid abuse in USA (SC)